Terms: = Head and neck cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Prognosis
59 results:
1. Identification and validation of an anoikis-related genes signature for prognostic implication in papillary thyroid cancer.
Zhao R; Lu Y; Wan Z; Qiao P; Yang L; Zhang Y; Huang S; Chen X
Aging (Albany NY); 2024 Apr; 16(8):7405-7425. PubMed ID: 38663918
[TBL] [Abstract] [Full Text] [Related]
2. Basal differentiation and expression status of SOX2 and KLF4 in basal layers are prognostic factors for disease-specific survival in oral squamous cell carcinoma.
Murakami K; Kamiakito T; Kawata H; Kosami K; Nakaya T; Noguchi T; Mori Y; Tanaka A
J Oral Pathol Med; 2024 May; 53(5):303-309. PubMed ID: 38659289
[TBL] [Abstract] [Full Text] [Related]
3. Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study.
Song Y; Jin Z; Li ZM; Liu Y; Li L; He C; Su H; Zhou H; Li K; Hao S; Zuo X; Wu J; Li D; Wu M; Sun X; Qi J; Cai Z; Li Z; Li Y; Huang Y; Shen J; Xiao Z; Zhu J
Clin Cancer Res; 2024 Apr; 30(7):1248-1255. PubMed ID: 38190117
[TBL] [Abstract] [Full Text] [Related]
4. A clinically useful and biologically informative genomic classifier for papillary thyroid cancer.
Craig S; Stretch C; Farshidfar F; Sheka D; Alabi N; Siddiqui A; Kopciuk K; Park YJ; Khalil M; Khan F; Harvey A; Bathe OF
Front Endocrinol (Lausanne); 2023; 14():1220617. PubMed ID: 37772080
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive nutritional index predicts clinical outcomes for esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy.
Feng J; Wang L; Yang X; Chen Q; Cheng X
Int Immunopharmacol; 2023 Aug; 121():110459. PubMed ID: 37307758
[TBL] [Abstract] [Full Text] [Related]
6. Validation of ezh2 Inhibitor Efficiency in Anaplastic Thyroid Carcinoma Cell Lines.
Nakayama H; Saito N; Kasajima R; Suganuma N; Rino Y; Masudo K; Yamazaki H; Toda S; Sekihara K; Iwasaki H; Hoshino D
Anticancer Res; 2023 Mar; 43(3):1073-1077. PubMed ID: 36854530
[TBL] [Abstract] [Full Text] [Related]
7. Molecular Evidence for Olfactory Neuroblastoma as a Tumor of Malignant Globose Basal Cells.
Zunitch MJ; Fisch AS; Lin B; Barrios-Camacho CM; Faquin WC; Tachie-Baffour Y; Louie JD; Jang W; Curry WT; Gray ST; Lin DT; Schwob JE; Holbrook EH
Mod Pathol; 2023 May; 36(5):100122. PubMed ID: 36841178
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of ezh2.
Duan Y; Yue K; Ye B; Chen P; Zhang J; He Q; Wu Y; Lai Q; Li H; Wu Y; Jing C; Wang X
Cell Death Dis; 2023 Feb; 14(2):149. PubMed ID: 36813772
[TBL] [Abstract] [Full Text] [Related]
9. head-and-neck dermatofibrosarcoma protuberans: Survival analysis and Clinically relevant immunohistochemical indicators.
Dai Z; He Y; Zhang X; Tian Z; Zhu G; Ren Z; Ye L; Liu Z; Ma C; Cao W; Ji T
Oral Dis; 2024 Apr; 30(3):1040-1051. PubMed ID: 36597156
[TBL] [Abstract] [Full Text] [Related]
10. Genome-wide gain-of-function screening identifies ezh2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma.
Xing H; Gao M; Wang Y; Zhang X; Shi J; Wang X; Liu X; Ma Q; Kong X; Yang C; Ding J; Meng L
Clin Transl Med; 2022 May; 12(5):e835. PubMed ID: 35604910
[TBL] [Abstract] [Full Text] [Related]
11. LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z; Zhong C; Shen J; Jia Y; Duan S
Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
[TBL] [Abstract] [Full Text] [Related]
12. EBF3 reactivation by inhibiting the EGR1/ezh2/HDAC9 complex promotes metastasis via transcriptionally enhancing vimentin in nasopharyngeal carcinoma.
Ding S; Wang X; Lv D; Tao Y; Liu S; Chen C; Huang Z; Zheng S; Wei Y; Kang T; Xia Y
Cancer Lett; 2022 Feb; 527():49-65. PubMed ID: 34906623
[TBL] [Abstract] [Full Text] [Related]
13. ezh2-mediated SLC7A11 upregulation via miR-125b-5p represses ferroptosis of TSCC.
Yu Y; MohamedAl-Sharani H; Zhang B
Oral Dis; 2023 Apr; 29(3):880-891. PubMed ID: 34614259
[TBL] [Abstract] [Full Text] [Related]
14. LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.
Yang X; Miao S; Mao X; Xiu C; Sun J; Pei R; Jia S
Pathol Oncol Res; 2021; 27():584466. PubMed ID: 34257531
[No Abstract] [Full Text] [Related]
15. [Analysis of the Predictive Value of ezh2 Expression Level on the Clinical Efficacy and Long-term prognosis of Patients with Primary Gastrointestinal Diffuse Large B-cell Lymphoma].
Lin JY; Zheng YB; He HM; Wang JS; Yang Y; Chen DG; Zou SP; Wang C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):725-730. PubMed ID: 34105464
[TBL] [Abstract] [Full Text] [Related]
16. Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-ezh2 signalling pathway.
Dev A; Sardoiwala MN; Kushwaha AC; Karmakar S; Choudhury SR
Phytomedicine; 2021 Jan; 80():153386. PubMed ID: 33113500
[TBL] [Abstract] [Full Text] [Related]
17. Long non-coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma.
Ding X; Qi C; Min J; Xu Z; Huang K; Tang H
J Cell Mol Med; 2020 Sep; 24(18):10551-10559. PubMed ID: 32729661
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in head and neck Squamous Cell Carcinoma.
Jin Y; Qin X
DNA Cell Biol; 2020 Oct; 39(10):1789-1798. PubMed ID: 32716650
[TBL] [Abstract] [Full Text] [Related]
19. Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma.
Huq S; Casaos J; Serra R; Peters M; Xia Y; Ding AS; Ehresman J; Kedda JN; Morales M; Gorelick NL; Zhao T; Ishida W; Perdomo-Pantoja A; Cecia A; Ji C; Suk I; Sidransky D; Brait M; Brem H; Skuli N; Tyler B
Mol Cancer Ther; 2020 Sep; 19(9):1797-1808. PubMed ID: 32606016
[TBL] [Abstract] [Full Text] [Related]
20. Data Mining Identifies Six Proteins that Can Act as Prognostic Markers for head and neck Squamous Cell Carcinoma.
Wu ZH; Yun-Tang ; Cheng Q
Cell Transplant; 2020; 29():963689720929308. PubMed ID: 32452220
[TBL] [Abstract] [Full Text] [Related]
[Next]
